China Biomedicine Clusters and Enterprises Investment and Collaboration

  • Recommend
  • Tweet
  • Print
  • Email

Wednesday, November 13, 2013, 2:10 p.m. - 4:25 p.m., Room 403

Organized by the China Investment Promotion Agency (CIPA)

Leader Speeches and Cluster Promotion 

2:10 p.m. – 2:25 p.m. 


Location Selection Strategy of Transnational Corporation and Environment Improvement of Economic and Technological Development Zone 

2:30 p.m. – 3:25 p.m. 
This panel will explore the different location selection standards interpreted by the overseas and domestic bio-enterprises as well as how best to collaborate with China clusters. The panel will also introduce the policy and service platform of China Biomedicine Clusters. Panelists • Shanghai Zhangjiang Biotech and Pharmaceutical Base Development Co, Ltd * Wuhan East Lake High-tech Zone * Meishan Economic Development Zone * Shanghai Newsummit Biopharma Group * Shanghai Roche Pharmaceuticals Ltd * Pfizer Investment Co, Ltd

Panelists

  • Shanghai Zhangjiang Biotech and Pharmaceutical Base Development Co, Ltd
  • ​Wuhan East Lake High-tech Zone
  • Meishan Economic Development Zone  
  • Shanghai Newsummit Biopharma Group
  • Shanghai Roche Pharmaceuticals Ltd
  • Pfizer Investment Co, Ltd

International Biotechnology Transfer and Industry Investment Fund 

3:30 pm – 4:25 pm 
This panel will look at current opportunities for global biotech transfer in China and what development funds are available to promote the development of the industry.

Panelists

  • Dave Tapolczay, CEO, Medical Research Council Technology
  • Samantha Du, Managing Director, Sequoia Capital
  • Richard Lim, Partner, Omega Fund
  • Syd Hanna, Partner, Elixir Ventures
  • Simon Haworth, Founder, Team Kapital
  • Qingdao High-Tech Industry Development Zone
  • Taizhou Medical High-Tech Zone